| $17M | ||
| $8M | ||
| $8M | ||
| $6M | ||
| $6M | ||
| $5M |
Buys | $0 | 0 | 0 |
Sells | $89,352,367 | 45 | 100 |
| RAKOWICH WALTER C | director | 0 | $0 | 1 | $93,026 | $-93,026 |
| Liebbe Gregory R | SVP, Chief Accounting Officer | 0 | $0 | 1 | $243,558 | $-243,558 |
| Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 0 | $0 | 9 | $1.13M | $-1.13M |
| Roberts Carey S. | EVP and GC | 0 | $0 | 1 | $1.51M | $-1.51M |
| Probst Robert F | EVP and CFO | 0 | $0 | 9 | $26.05M | $-26.05M |
| CAFARO DEBRA A | Chairman and CEO | 0 | $0 | 24 | $60.33M | $-60.33M |
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Over the last 12 months, insiders at Ventas, Inc. have bought $0 and sold $89.35M worth of Ventas, Inc. stock.
On average, over the past 5 years, insiders at Ventas, Inc. have bought $0 and sold $27.48M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $580,101 was made by CROCKER DOUGLAS II (director) on 2013‑12‑10.
| 2026-01-02 | Sale | CAFARO DEBRA A | Chairman and CEO | 10,322 0.0023% | $77.26 | $797,475 | -0.67% | |
| 2026-01-02 | Sale | Probst Robert F | EVP and CFO | 29,930 0.0068% | $77.25 | $2.31M | -0.67% | |
| 2025-12-01 | Sale | CAFARO DEBRA A | Chairman and CEO | 10,322 0.0023% | $80.55 | $831,419 | -3.50% | |
| 2025-11-19 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 2,229 0.0005% | $80.08 | $178,504 | -1.50% | |
| 2025-11-18 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 2,771 0.0006% | $80.01 | $221,701 | -1.13% | |
| 2025-11-17 | Sale | CAFARO DEBRA A | Chairman and CEO | 41,294 0.0093% | $79.01 | $3.26M | +0.15% | |
| 2025-11-12 | Sale | Probst Robert F | EVP and CFO | 33,591 0.0077% | $76.77 | $2.58M | +2.60% | |
| 2025-11-07 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 40 <0.0001% | $75.70 | $3,028 | +3.57% | |
| 2025-11-06 | Sale | CAFARO DEBRA A | Chairman and CEO | 264 <0.0001% | $75.05 | $19,813 | +4.64% | |
| 2025-11-06 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 166 <0.0001% | $75.15 | $12,475 | +4.64% | |
| 2025-11-05 | Sale | CAFARO DEBRA A | Chairman and CEO | 19,250 0.0044% | $75.29 | $1.45M | +4.13% | |
| 2025-11-05 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 870 0.0002% | $75.28 | $65,494 | +4.13% | |
| 2025-11-04 | Sale | CAFARO DEBRA A | Chairman and CEO | 11,452 0.0026% | $75.02 | $859,147 | +4.16% | |
| 2025-11-04 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 3,924 0.0009% | $75.00 | $294,287 | +4.16% | |
| 2025-11-03 | Sale | CAFARO DEBRA A | Chairman and CEO | 20,644 0.0047% | $73.86 | $1.52M | +5.22% | |
| 2025-10-30 | Sale | CAFARO DEBRA A | Chairman and CEO | 317,258 0.0741% | $74.24 | $23.55M | +4.55% | |
| 2025-10-20 | Sale | CAFARO DEBRA A | Chairman and CEO | 34,232 0.0075% | $71.32 | $2.44M | +8.14% | |
| 2025-10-01 | Sale | CAFARO DEBRA A | Chairman and CEO | 10,322 0.0023% | $70.24 | $724,986 | +9.21% | |
| 2025-10-01 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 2,554 0.0006% | $70.26 | $179,435 | +9.21% | |
| 2025-09-30 | Sale | Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 2,040 0.0004% | $69.99 | $142,780 | +9.70% |
| CAFARO DEBRA A | Chairman and CEO | 1145695 0.2439% | $88.21M | 0 | 166 | |
| Probst Robert F | EVP and CFO | 138434 0.0295% | $10.66M | 0 | 17 | |
| Roberts Carey S. | EVP and GC | 116650 0.0248% | $8.98M | 0 | 1 | |
| Bulgarelli Peter J. | EVP OM&R-Ventas/Pres&CEO-LHS | 106488 0.0227% | $8.2M | 0 | 16 | |
| RAKOWICH WALTER C | director | 27454 0.0058% | $2.11M | 0 | 3 | |
| Liebbe Gregory R | SVP, Chief Accounting Officer | 11371 0.0024% | $875,420.75 | 0 | 5 | |
| PROMETHEUS SENIOR QUARTERS LLC | 3700186 0.7877% | $284.88M | 0 | 2 | ||
| LFCM Holdings LLC | 3700186 0.7877% | $284.88M | 0 | 2 | ||
| LEWIS RAYMOND J | President | 170634 0.0363% | $13.14M | 0 | 9 | |
| SCHWEINHART RICHARD A | Senior Advisor to the CEO | 140628 0.0299% | $10.83M | 0 | 3 | |
| Lillibridge Todd W. | EVP, Medical Prop. Operations | 135538 0.0289% | $10.44M | 0 | 1 | |
| RINEY T RICHARD | EVP, Chief Admin. Off., GC | 133786 0.0285% | $10.3M | 0 | 59 | |
| CROCKER DOUGLAS II | director | 104164 0.0222% | $8.02M | 1 | 4 | +15.43% |
| PASQUALE DOUGLAS M | director | 104022 0.0221% | $8.01M | 0 | 15 | |
| Cobb John D. | EVP, Chief Investment Off. | 69609 0.0148% | $5.36M | 0 | 5 | |
| SHELTON JAMES D | director | 59080 0.0126% | $4.55M | 0 | 3 | |
| Reed Robert D. | director | 55607 0.0118% | $4.28M | 0 | 3 | |
| GILCHRIST RICHARD I | director | 35270 0.0075% | $2.72M | 1 | 1 | +17.26% |
| Brehl Robert J | Chief Acct. Off. & Controller | 26167 0.0056% | $2.01M | 0 | 2 | |
| Wood Brian K | SVP-Tax | 22213 0.0047% | $1.71M | 0 | 4 | |
| GEARY RONALD G | director | 18450 0.0039% | $1.42M | 0 | 7 | |
| THEOBALD THOMAS C | director | 16949 0.0036% | $1.3M | 2 | 3 | +23.76% |
| Doman Timothy A | SVP-Asset Management | 11905 0.0025% | $916,602.29 | 0 | 4 | |
| Cozzi Vincent M. | SVP Medical Office Properties | 9051 0.0019% | $696,836.49 | 0 | 3 | |
| Barnes Melody C | director | 4667 0.001% | $359,312.33 | 0 | 1 | |
| LUSTIG MATTHEW J | director | 0 0% | $0 | 0 | 2 |
$14,057,252 | 73 | 11.68% | $3.79B | |
$31,136,917 | 60 | 12.48% | $12.91B | |
$3,321,013 | 56 | -2.24% | $12.56B | |
$1,901,544 | 29 | 21.57% | $4.69B | |
$60,705,795 | 24 | 6.32% | $472.04M | |
$9,592,167 | 21 | 12.81% | $126.06B | |
$2,117,106 | 11 | 13.65% | $1.74B | |
$1,515,149 | 10 | 19.86% | $174.18M | |
Ventas, Inc. (VTR) | $952,734 | 4 | 20.05% | $36.16B |
| Increased Positions | 463 | +59.36% | 32M | +7.13% |
| Decreased Positions | 327 | -41.92% | 21M | -4.74% |
| New Positions | 109 | New | 3M | New |
| Sold Out Positions | 75 | Sold Out | 3M | Sold Out |
| Total Postitions | 916 | +17.44% | 456M | +2.39% |
| Vanguard Group Inc | $5.69M | 15.66% | 73.6M | +2M | +2.51% | 2025-09-30 |
| Blackrock, Inc. | $4.04M | 11.13% | 52.29M | +1M | +2.58% | 2025-09-30 |
| Jpmorgan Chase & Co | $2.3M | 6.32% | 29.7M | +387,495 | +1.32% | 2025-09-30 |
| State Street Corp | $2.24M | 6.16% | 28.93M | +928,386 | +3.32% | 2025-09-30 |
| Fmr Llc | $2.08M | 5.74% | 26.96M | +3M | +12.13% | 2025-09-30 |
| Principal Financial Group Inc | $1.19M | 3.28% | 15.42M | -379,260 | -2.4% | 2025-09-30 |
| Geode Capital Management, Llc | $967,654.00 | 2.66% | 12.51M | +287,027 | +2.35% | 2025-09-30 |
| Apg Asset Management Us Inc. | $909,284.00 | 2.5% | 11.76M | 0 | 0% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $554,913.00 | 1.53% | 7.18M | -435,414 | -5.72% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $510,466.00 | 1.4% | 6.6M | +160,998 | +2.5% | 2025-09-30 |